tbuckley/cabot-search huggingface dataset:
Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence
Authors: Mi Ah Han, Dena Zeraatkar, Gordon H. Guyatt, Robin W.M. Vernooij, Regina El Dib, Ying Zhang, Abdullah Algarni, Gareth Leung, Dawid Storman, Claudia Valli, Montserrat Rabassa, Nadia Rehman, Michael K. Parvizian, Max Zworth, Jessica J. Bartoszko, Luciane Cruz Lopes, Daegan Sit, Malgorzata M. Bala, Pablo Alonso-Coello, Bradley C. Johnston
Journal: Annals of Internal Medicine (2019)

This article has been corrected. The original version (PDF) is appended to this article as a Supplement. Background: Cancer incidence has continuously increased over the past few centuries and represents a major health burden worldwide. Purpose: To evaluate the possible causal relationship between intake of red and processed meat and cancer mortality and incidence. Data Sources: Embase, Cochrane Central Register of Controlled Trials, Web of Science, CINAHL, and ProQuest from inception until July 2018 and MEDLINE from inception until April 2019 without language restrictions. Study Selection: Cohort studies that included more than 1000 adults and reported the association between consumption of unprocessed red and processed meat and cancer mortality and incidence. Data Extraction: Teams of 2 reviewers independently extracted data and assessed risk of bias; 1 reviewer evaluated the certainty of evidence, which was confirmed or revised by the senior reviewer. Data Synthesis: Of 118 articles (56 cohorts) with more than 6 million participants, 73 articles were eligible for the dose–response meta-analyses, 30 addressed cancer mortality, and 80 reported cancer incidence. Low-certainty evidence suggested that an intake reduction of 3 servings of unprocessed meat per week was associated with a very small reduction in overall cancer mortality over a lifetime. Evidence of low to very low certainty suggested that each intake reduction of 3 servings of processed meat per week was associated with very small decreases in overall cancer mortality over a lifetime; prostate cancer mortality; and incidence of esophageal, colorectal, and breast cancer. Limitation: Limited causal inferences due to residual confounding in observational studies, risk of bias due to limitations in diet assessment and adjustment for confounders, recall bias in dietary assessment, and insufficient data for planned subgroup analyses. Conclusion: The possible absolute effects of red and processed meat consumption on cancer mortality and incidence are very small, and the certainty of evidence is low to very low. Primary Funding Source: None. (PROSPERO: CRD42017074074)
Hyperphosphatemia due to erdafitinib (a pan-FGFR Inhibitor) and anti-tumour activity among patients (Pts) with advanced urothelial carcinoma (UC)
Authors: S. Tagawa, A. Siefker-Radtke, A.-G. Dosne, B. Zhong, K. Qi, W. Shalaby, A. O’Hagan, P. De Porre, P. Mahadevia, Y. Loriot
Journal: Annals of Oncology (2019)
Role of individualized intervention(s) on quality of life (QoL) and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer (bc): MyChoice study
Authors: S. Ahmed, H.I. Chalchal, L. Dwernychuk, N. Iqbal, M. Salim, D. Gowan-Moody, T. Asif, M. Khan, J. Lim, D. Bulych, O. Ahmed, A. Sami, S. Kontulainen, A. Leis
Journal: Annals of Oncology (2019)
Adolescent Consent to Vaccination in the Age of Vaccine-Hesitant Parents
Authors: Y. Tony Yang, Robert S. Olick, Jana Shaw
Journal: JAMA Pediatrics (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Pediatrics HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Pediatrics journal
P04.15 Impact of histone lysine methyltransferases SETDB1, SETD2, SUV39H1, MLL2, EZH2and their corresponding histone marks in pediatric astrocytomas
Authors: A Klonou, P Korkolopoulou, A N Gargalionis, M Themistocleous, S Sgouros, A G Papavassiliou, C Piperi
Journal: Neuro-Oncology (2019)

Abstract BACKGROUND Pediatric brain tumors are characterized by altered epigenetic profiles and deregulated chromatin remodelling that affects gene expression. Histone lysine methylation has emerged as important chromatin function regulator, with potential role in glioma formation. Τhis study investigates the expression of histone lysine methyltransferases (SETDB1, SUV39H1, EZH2, MLL2, SETD2) and their corresponding methylation marks (H3K9me3, H3K27me3, H3K4me2/3, H3K36me3) in pediatric astrocytomas. MATERIAL AND METHODS Thirty-four (34) archival pediatric astrocytomas [27 low grade (I/II) and 7 high grade (III/IV) tumors; 21 males, 13 females; 1–15 years old] and 5 postmortem normal brain samples were studied. Methyltransferases expression and histone marks were detected by immunohistochemistry as H-score (intensity multiplied with cell percentage, 0–300) and validated by western blot. RESULTS Elevated nuclear SETD2 and SETDB1 staining was observed in all astrocytomas (median H-score:165 and 110, respectively). SETDB1 and SETD2 expression levels were positively associated (p=0.004), being higher in high grade compared to lower grade tumors (p=0.001, p=0.027, respectively). Furthermore, SETDB1 staining was significantly increased in male children (p=0.051) and negatively associated with patients age (p=0.028). A moderate nuclear and cytoplasmic staining was obtained for MLL2 at low grade (median H-score:84) compared to high grade tumors (median H-score:144). In accordance, lower SUV39H1 nuclear and cytoplasmic expression was detected in low grade tissues (median H score:85) compared to high grade (median H-score:160). EZH2 presented no significant nuclear expression. Increased nuclear staining of H3K9me3 and H4K20me3 repressive marks was observed in astrocytomas (median H-score:297 and 270, respectively), being positively associated (p=0.02). Elevated nuclear staining of H3K4me3 active mark (median H-score:210) was detected in astrocytomas, being significantly higher in high grade tumors (p=0.025) and in male children (p=0.036). CONCLUSION SETDB1, SETD2, SUV39H1 and MLL2 may play a significant role in modulating gene expression in pediatric astrocytomas. Increased presence of H3K9me3, H4K20me3 and H3K4me3 histone marks signifies their possible participation in gliomagenesis. Larger cohort studies need to elucidate the functional significance and underlying molecular mechanisms of these chromatin-modifying enzymes and respective histone changes in pediatric astrocytomas.
Tobacco retail access and tobacco cessation among head and neck cancer (HNC) survivors
Authors: L. Eng, J. Su, K. Hueniken, M.C. Brown, D.P. Saunders, J.R. de Almeida, A. Hope, P. Selby, A. Spreafico, A.R. Hansen, D.P. Goldstein, W. Xu, M.E. Giuliani, W.K. Evans, G. Liu, M. Chaiton
Journal: Annals of Oncology (2019)
Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
Authors: V. Randrian, A. Adenis, J. Desrame, E. Barbier, F. Di Fiore, A. Lievre, L. Dahan, P. Laurent-Puig, L. Mineur, G. Breysacher, G. Roquin, S. Louafi, A. Lopez, C. Louvet, C. Borg, J.-P. Metges, R. Faroux, L. Gaba, S. Manfredi, D. Tougeron
Journal: Annals of Oncology (2019)
Finding the right biomarker for renal cell carcinoma (RCC): Nivolumab treatment induces the expression of specific peripheral lymphocyte microRNAs in patients with durable and complete response
Authors: L. Incorvaia, D. Fanale, G. Badalamenti, J.L. Iovanna, L. Corsini, A. Simonato, V. Bazan, C.G. Porta, A. Russo
Journal: Annals of Oncology (2019)
Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040
Authors: E. Cohen, K. Harrington, D. Soulières, C. Le Tourneau, L.F. Licitra, B. Burtness, T. Bal, J. Juco, D. Aurora-Garg, L. Huang, R.F. Swaby, K. Emancipator
Journal: Annals of Oncology (2019)
Pembrolizumab in advanced rare cancers
Authors: A. Naing, F. Meric-Bernstam, D. Karp, J.A. Rodon, S.A. Piha-Paul, V. Subbiah, D.S. Hong, S. Pant, S. Fu, F. Janku, T.A. Yap, A.M. Tsimberidou, E E Ileana Dumbrava, R.R. Colen, K.R. Hess, M.T. Campbell, S.-M. Tu, C. Jimenez, M.A. Habra, G.R. Varadhachary
Journal: Annals of Oncology (2019)
Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial
Authors: J. Xu, T. Liu, W. Tang, W. Chang, Q. Feng, Y. Wei, L. Ren, Q. Ye, Y. Cui, G. He, T. Liu, D. Zhu, M. Ji
Journal: Annals of Oncology (2019)
High Serum Lactate Dehydrogenase (LDH) Is An Important Prognostic Factor in the Era of Novel Agents and Adds to the Prognostic Value of the International Staging System (ISS) in Patients with Multiple Myeloma.
Authors: Dimopoulos A. Dimopoulos, Maria Roussou, Anastasia Pouli, Eirini Katodritou, Argiris Symeonidis, Eurydiki Michalis, Vassiliki Grigoraki, Nikolaos Anagnostopoulos, Athanasios Zomas, Sosana Delimpasi, Agapi Parharidou, Zafiris Kartasis, Nora-Athina Viniou, Dimitra Gika, Evangelos Terpos, Theofanis Economopoulos, Konstantinos Zervas
Journal: Blood (2009)
Safety of lorlatinib in subgroups of patients from a phase I/II trial
Authors: E. Felip, B.J. Solomon, B. Besse, T.M. Bauer, R.A. Soo, D.R. Camidge, R. Chiari, A. Bearz, C.-C. Lin, S.M. Gadgeel, E.-H. Tan, T. Seto, G.R. Oxnard, G. Peltz, A. Abbattista, H. Thurm, F. Toffalorio, S-H I Ou, A.T. Shaw
Journal: Annals of Oncology (2019)
Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?
Authors: M. Giavarra, E. Bertoli, V. Buoro, D. Zara, G. Targato, L. Palmero, M.G. Vitale, G. Pelizzari, D. Basile, L. Gerratana, M. Bonotto, C. Andreetta, M. Cinausero, G. Pascoletti, E. Poletto, S. Russo, F. Puglisi, G. Fasola, M. Mansutti, A.M. Minisini
Journal: Annals of Oncology (2019)
Extracellular matrix and tissue derived metabolites in a liquid biopsy identifies endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment
Authors: N. Willumsen, C.L. Bager, C. Jensen, M.A. Karsdal, D.H. Madsen, M. Hansen, H. Schmidt, I.M. Svane
Journal: Annals of Oncology (2019)
THE ROLE OF DOBUTAMINE IN THE HEMODYNAMIC ASSESSMENT OF MYOCARDIAL BRIDGING: CORRELATIONS BETWEEN STRESS-INDUCED MYOCARDIAL ISCHEMIA, FRACTIONAL FLOW RESERVE AND QUANTITATIVE CORONARY ANGIOGRAPHY MEASUREMENTS
Authors: Srdjan Aleksandric, Ana Djordjevic-Dikic, Milan Dobric, Jelena Stepanovic, Vojislav Giga, Marko Banovic, Vladan Vukcevic, Miloje Tomasevic, Sinisa Stojkovic, Dejan Orlic, Jovica Saponjski, Milan Nedeljkovic, Goran Stankovic, Miodrag Ostojic, Branko Beleslin
Journal: Journal of the American College of Cardiology (2019)
Analysis of molecular profile complexities for immunotherapy decision support
Authors: R. Dóczi, D. Tihanyi, P. Filotas, A. Dirner, B. Pálházi, E. Várkondi, Z. Farkas, J. Deri, E. Lengyel, C. Hegedus, I. Petak
Journal: Annals of Oncology (2019)
An adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies
Authors: T. Powles, A. Balar, G. Gravis, R. Jones, A. Ravaud, J. Florence, P. Grivas, D.P. Petrylak, M. Galsky, J. Carles, S. Sridhar, H.-T. Arkenau, D. Carroll, J. DeCesare, F. Mercier, D. Hodgson, J. Stone, J. Cosaert, D. Landers
Journal: Annals of Oncology (2019)
Epigenomic signatures underpin the axonal regenerative ability of dorsal root ganglia sensory neurons
Authors: Ilaria Palmisano, Matt C. Danzi, Thomas H. Hutson, Luming Zhou, Eilidh McLachlan, Elisabeth Serger, Kirill Shkura, Prashant K. Srivastava, Arnau Hervera, Nick O’ Neill, Tong Liu, Hassen Dhrif, Zheng Wang, Miroslav Kubat, Stefan Wuchty, Matthias Merkenschlager, Liron Levi, Evan Elliott, John L. Bixby, Vance P. Lemmon, Simone Di Giovanni
Journal: Nature Neuroscience (2019)
Changes in hormone-receptor status in luminal breast cancers between primary tumour and metastases: Results of the observational cohort GIM-13 AMBRA study
Authors: M.E. Cazzaniga, P. Pronzato, L. Del Mastro, C. Natoli, F. Montemurro, G. Bisagni, L. Blasi, A. Turletti, M. Giordano, L. Biganzoli, A. Michelotti, O. Garrone, P. Marchetti, F. Riccardi, A. Bernardo, L. Livi, F. Cognetti, M. Donadio, E. Romagnoli, G. Mustacchi
Journal: Annals of Oncology (2019)
HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma
Authors: Baharan Fekry, Aleix Ribas-Latre, Corrine Baumgartner, Alaa M.T. Mohamed, Mikhail G. Kolonin, Frances M. Sladek, Mamoun Younes, Kristin L. Eckel-Mahan
Journal: Cancer Research (2019)

Abstract The incidence of hepatocellular carcinoma (HCC) is on the rise worldwide. Although the incidence of HCC in males is considerably higher than in females, the projected rates of HCC incidence are increasing for both sexes. A recently appreciated risk factor for HCC is the growing problem of nonalcoholic fatty liver disease, which is usually associated with obesity and the metabolic syndrome. In this study, we showed that under conditions of fatty liver, female mice were more likely to develop HCC than expected from previous models. Using an inducible knockout model of the tumor-suppressive isoform of hepatocyte nuclear factor 4 alpha (“P1-HNF4α”) in the liver in combination with prolonged high fat (HF) diet, we found that HCC developed equally in male and female mice as early as 38 weeks of age. Similar sex-independent HCC occurred in the “STAM” model of mice, in which severe hyperglycemia and HF feeding results in rapid hepatic lipid deposition, fibrosis, and ultimately HCC. In both sexes, reduced P1-HNF4α activity, which also occurs under chronic HF diet feeding, increased hepatic lipid deposition and produced a greatly augmented circadian rhythm in IL6, a factor previously linked with higher HCC incidence in males. Loss of HNF4α combined with HF feeding induced epithelial–mesenchymal transition in an IL6-dependent manner. Collectively, these data provide a mechanism-based working hypothesis that could explain the rising incidence of aggressive HCC. Significance: This study provides a mechanism for the growing incidence of hepatocellular carcinoma in both men and women, which is linked to nonalcoholic fatty liver disease.
Update of the registry of young women with cancer by the International Network of Cancer, Infertility and Pregnancy
Authors: C. Maggen, K. Van Calsteren, E. Cardonick, R.G. Shmakov, M. Gziri, A.C. Garcia, R. Fruscio, C.A.R. Lok, M. Halaska, I.A. Boere, P. Zola, P. Ottevanger, C.J.M. de Groot, G. Scarfone, M. Fumagalli, R.C. Painter, J. de Haan, F. Amant
Journal: Annals of Oncology (2019)
Comprehensive pan-cancer analysis of KRAS genomic alterations (GA) including potentially targetable subsets
Authors: S -H I Ou, E.S. Sokol, R. Madison, J. Chung, J.S. Ross, V.A. Miller, B.M. Alexander, S.M. Ali, A.B. Schrock, S.S. Ramalingam
Journal: Annals of Oncology (2019)
IO-synthesise NSCLC: A pooled analysis of real-world survival outcomes for non-small cell lung cancer patients treated with nivolumab in France and Germany
Authors: None Dixmier, B. Asselain, F. Barlesi, D. Debieuvre, C Audigier Valette, A. Gröschel, S. Gütz, R. Liersch, D. Moro-Sibilot, H. Müller-Huesmann, M. Perol, C. Raspaud, C. Schulte, H. Schulz, C. Schumann, V. Allan, C.Y. Calvet, K.J. Rothnie, V. Wünsch, M. Sebastian
Journal: Annals of Oncology (2019)
Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results From Three Large Prospective U.S. Cohorts of Women and Men
Authors: Jean-Philippe Drouin-Chartier, Yan Zheng, Yanping Li, Vasanti Malik, An Pan, Shilpa N. Bhupathiraju, Deirdre K. Tobias, JoAnn E. Manson, Walter C. Willett, Frank B. Hu
Journal: Diabetes Care (2019)

OBJECTIVE We evaluated the associations of long-term changes in consumption of sugary beverages (including sugar-sweetened beverages and 100% fruit juices) and artificially sweetened beverages (ASBs) with subsequent risk of type 2 diabetes. RESEARCH DESIGN AND METHODS We followed up 76,531 women in the Nurses’ Health Study (1986–2012), 81,597 women in the Nurses’ Health Study II (1991–2013), and 34,224 men in the Health Professionals’ Follow-up Study (1986–2012). Changes in beverage consumption (in 8-ounce servings/day) were calculated from food frequency questionnaires administered every 4 years. Multivariable Cox proportional regression models were used to calculate hazard ratios for diabetes associated with changes in beverage consumption. Results of the three cohorts were pooled using an inverse variance–weighted, fixed-effect meta-analysis. RESULTS During 2,783,210 person-years of follow-up, we documented 11,906 incident cases of type 2 diabetes. After adjustment for BMI and initial and changes in diet and lifestyle covariates, increasing total sugary beverage intake (including both sugar-sweetened beverages and 100% fruit juices) by &amp;gt;0.50 serving/day over a 4-year period was associated with a 16% (95% CI 1%, 34%) higher diabetes risk in the subsequent 4 years. Increasing ASB consumption by &amp;gt;0.50 serving/day was associated with 18% (2%, 36%) higher diabetes risk. Replacing one daily serving of sugary beverage with water, coffee, or tea, but not ASB, was associated with a 2–10% lower diabetes risk. CONCLUSIONS Increasing consumption of sugary beverages or ASBs was associated with a higher risk of type 2 diabetes, albeit the latter association may be affected by reverse causation and surveillance bias.
Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden
Authors: Charlotte Skoglund, Helena Kopp Kallner, Alkistis Skalkidou, Anna-Karin Wikström, Cecilia Lundin, Susanne Hesselman, Anna Wikman, Inger Sundström Poromaa
Journal: JAMA Network Open (2019)

<h3>Importance</h3> Attention-deficit/hyperactivity disorder (ADHD) is associated with a plethora of adverse health outcomes throughout life. While Swedish specialized youth clinics have carefully and successfully targeted risk of unplanned pregnancies in adolescents, important risk groups, such as women and girls with ADHD, might not be identified or appropriately assisted by these interventions. <h3>Objectives</h3> To determine whether women and girls with ADHD are associated with increased risk of teenage birth compared with their unaffected peers and to examine the association of ADHD with risk factors for adverse obstetric and perinatal outcomes, such as smoking, underweight or overweight, and substance use disorder. <h3>Design, Setting, and Participants</h3> This nationwide cohort study included data from 6 national longitudinal population-based registries in Sweden. All nulliparous women and girls who gave birth in Sweden between January 1, 2007, and December 31, 2014, were included. Data analyses were conducted from October 7, 2018, to February 8, 2019. <h3>Exposures</h3> Women and girls treated with stimulant or nonstimulant medication for ADHD (Anatomic Therapeutic Chemical classification code N06BA) in the Swedish Prescribed Drug Register between July 1, 2005, and December 31, 2014. <h3>Main Outcomes and Measures</h3> Maternal age at birth. Secondary outcome measures were body mass index, smoking habits, and psychiatric comorbidities. <h3>Results</h3> Among 384 103 nulliparous women and girls aged 12 to 50 years who gave birth between 2007 and 2014 included in the study, 6410 (1.7%) (mean [SD] age, 25.0 [5.5] years) were identified as having ADHD. The remaining 377 693 women and girls without ADHD (mean [SD] age, 28.5 [5.1] years) served as the control group. Teenage deliveries were more common among women and girls with ADHD than among women and girls without ADHD (15.3% vs 2.8%; odds ratio [OR], 6.23 [95% CI, 5.80-6.68]). Compared with women and girls without ADHD, those with ADHD were more likely to present with risk factors for adverse obstetric and perinatal outcomes, including smoking during the third trimester (OR, 6.88 [95% CI, 6.45-7.34]), body mass index less than 18.50 (OR, 1.29 [95% CI, 1.12-1.49]), body mass index more than 40.00 (OR, 2.01 [95% CI, 1.60-2.52]), and alcohol and substance use disorder (OR, 20.25 [95% CI, 18.74-21.88]). <h3>Conclusions and Relevance</h3> This study found that women and girls with ADHD were associated with an increased risk of giving birth as teenagers compared with their unaffected peers. The results suggest that standard of care for women and girls with ADHD should include active efforts to prevent teenage pregnancies.
Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel
Authors: Tao Bai, Jianqiang Li, Andrew Sinclair, Suzan Imren, Fabiola Merriam, Fang Sun, Mary Beth O’Kelly, Cynthia Nourigat, Priyesh Jain, Jeffrey J. Delrow, Ryan S. Basom, Hsiang-Chieh Hung, Peng Zhang, Bowen Li, Shelly Heimfeld, Shaoyi Jiang, Colleen Delaney
Journal: Nature Medicine (2019)
Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study
Authors: J. Bourhis, X. Sun, Y. Pointreau, C. Sire, C. Le Tourneau, Alexandre Coutte, M-C. Kaminsky-Forrett, M. Alfonsi, P. Boisselier, L. Martin, J-P. Delord, F. Clatot, J. Miroir, F. Rolland, P. Crompton, S. Brienza, S. A. Szyldergemajn, C. Even, Y. Tao
Journal: Annals of Oncology (2019)
First-in-human study of ABBV-621 in patients (pts) with previously treated sold tumours: Dose-optimization cohorts
Authors: E. Calvo, M.J.A. de Jonge, D.W. Rasco, V. Moreno, Y.-W. Chang, M. Chiney, M. Motwani, S. Penugonda, A.M. Petrich, M.J. Ratain, P. LoRusso
Journal: Annals of Oncology (2019)
Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: A multi-center comparative study
Authors: I. Meattini, L. Livi, K. Kim, J. Kim, W. Jung, E. Olmetto, I. Desideri, C. Saieva, C. Becherini, V. Salvestrini, A. Fourquet, Y. Kirova, P. Poortmans
Journal: Annals of Oncology (2019)